BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir

Wen Fang Tang, Yu Hsiu Chang, Cheng Chin Lin, Jia Rong Jheng, Chung Fan Hsieh, Yuan Fan Chin, Tein Yao Chang, Jin Ching Lee, Po Huang Liang, Chia Yi Lin, Guan Hua Lin, Jie Yun Cai, Yu Li Chen, Yuan Siao Chen, Shan Ko Tsai, Ping Cheng Liu, Chuen Mi Yang, Tolou Shadbahr, Jing Tang, Yu Lin HsuChih Heng Huang, Ling Yu Wang, Cheng Cheung Chen, Jyh Hwa Kau, Yi Jen Hung, Hsin Yi Lee, Wen Chieh Wang, Hui Ping Tsai*, Jim Tong Horng*

*Corresponding author for this work

Research output: Contribution to journal › Journal Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science